Stiff-person syndrome: Insights into a complex autoimmune disorder

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 8, 2015, Pages 840-848

  Baizabal Carvallo, Jos Fidel ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPRAZOLAM; AMPHIPHYSIN; BACLOFEN; BOTULINUM TOXIN; CLOMIPRAMINE; CLONAZEPAM; DANTROLENE; DIAZEPAM; ETIRACETAM; GABAPENTIN; GLUTAMATE DECARBOXYLASE; GLYCINE; GLYCINE RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MILACEMIDE; NEUROTRANSMITTER; PREGABALIN; PROPOFOL; RESERPINE; TIAGABINE; TIZANIDINE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BREAST CANCER; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ENCEPHALOMYELITIS; GABAERGIC SYSTEM; HUMAN; IMMUNOTHERAPY; INCIDENCE; MUSCLE SPASM; MYOCLONUS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; RIGIDITY; STIFF MAN SYNDROME; T LYMPHOCYTE; ADULT; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PATHOPHYSIOLOGY; STIFF-PERSON SYNDROME; YOUNG ADULT;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS; STIFF-PERSON SYNDROME; YOUNG ADULT;

EID: 84939480586     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309201     Document Type: Review

References (104)

1. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin 1956;31:421-7.
2. Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord 1991;6:12-20.
3. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord 2012;27:935-46.
4. Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol 2009;11:102-10.
5. Barker RA, Revesz T, Thom M, et al. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998;65:633-40.
6. McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol 2012;69:230-8.
7. Leigh PN, Rothwell JC, Traub M, et al. A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome". J Neurol Neurosurg Psychiatry 1980;43:1125-31.
8. Alberca RA, Romero M, Chaparro J. Jerking stiff-man syndrome. J Neurol Neurosurg Psychiatry 1982;45:1159-60.
9. Mas N, Saiz A, Leite MI, et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosug Psychiatry 2011;82:1399-401.
10. Meinck HM, Ricker K, Hulser PJ, et al. Stiff man syndrome: neurophysiological findings in eight patients. J Neurol 1995;242:134-2.
11. Economides JR, Horton JC. Eye movement abnormalities in stiff person syndrome. Neurology 2005;65:1462-4.
12. Oskarsson B, Pelak V, Quan D, et al. Stiff eyes in stiff-person syndrome. Neurology 2008;71:378-80.
13. Berger C, Meinck HM. Head retraction reflex in stiff-man syndrome and related disorders. Mov Disord 2003;18:906-11.
14. Mitsumoto H, Schwartzman MJ, Estes ML, et al. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol 1991;238:91-6.
15. Tinsley JA, Barth EM, Black JL, et al. Psychiatric consultations in stiff-man syndrome. J Clin Psychiatry 1997;58:444-9.
16. Henningsen P, Meinck HM. Specific phobia is a frequent non-motor feature in stiff man syndrome. J Neurol Neurosurg Psychiatry 2003;74:462-5.
17. Murinson BB, Murinson JB. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 2008;71:1955-8.
18. Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005;58:96-107.
19. Sommer CA, Wishaupt A, Brinkoff J, et al. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005;365:1406-11.
20. Petzold GC, Marcucci M, Butler MH, et al. Rhabomyolysis and paraneoplastic stiff-man syndrome with amphiphysin autoimmunity. Ann Neurol 2004;55: 286-90.
21. Butler MH, Hayashi A, Ohkoshi N, et al. Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000;26:307-12.
22. Thümen A, Moser A. An uncommon paraneoplastic Ri-positive opsoclonus-myoclonus-like syndrome and stiff-person syndrome with elevated glutamate/GABA ratio in the cerebrospinal fluid after breast cancer. J Neurol 2010;257:1215-17.
23. Campbell AM, Garland H. Subacute myoclonic spinal neuronitis. J Neurol Neurosug Psychiatry 1956;19:268-74.
24. Duddy ME, Baker MR. Stiff person syndrome. Front Neurol Neurosci 2009;29:147-65.
25. Piotrowicz A, Thümen A, Leite MI, et al. A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. J Neurol 2011;258:2268-70.
26. Solimena M, Folli F, Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-20.
27. Ali F, Rowley M, Jayakrishnan B, et al. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun 2011;37:79-87.
28. Erlander MG, Tillakaratne NJ, Feldblum S, et al. Two genes encode distinct glutamate decarboxylases. Neuron 1991;7:91-100.
29. Solimena M, Folli F, Aparisi R, et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322: 1555-60.
30. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-63.
31. Raju R, Foote J, Banga JP, et al. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J Immunol 2005;175:7755-62.
32. Chéramy M, Hampe CS, Ludvigsson J, et al. Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals. Clin Exp Immunol 2013;171:247-54.
33. Daw K, Ujihara N, Atkinson M, et al. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 1996;156:818-25.
34. Butler MH, Solimena M, Dirkx R Jr. et al. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 1993;178:2097-106.
35. Dinkel K, Meinck HM, Jury KM, et al. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201.
36. Kim J, Namchuk M, Bugawan T, et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 1994;180:595-606.
37. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993;90:2832-6.
38. Chang T, Alexopoulos H, McMenamin M, et al. Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome. JAMA Neurol 2013;70:1140-9.
39. Mitoma H, Song SY, Ishida K, et al. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 2000;175:40-4.
40. Vianello M, Bisson G, Dal Maschio M, et al. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 2008;41:66-73.
41. Manto MU, Laute MA, Aguera M, et al. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007;61:544-51.
42. Geis C, Weishaupt A, Hallermann S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 2010;133:3166-80.
43. Geis C, Weishaupt A, Grünewald B, et al. Human stiff-person syndrome IgG induces anxious behaviour in rats. PLoS ONE 2011;6:e16775.
44. Geis C, Grünewald B, Weishaupt A, et al. Human IgG directed against amphiphysin induces anxiety behaviour in a rat model after intrathecal passive transfer. J Neural Transm 2012;119:981-5.
45. Manto MU, Hampe CS, Rogemond V, et al. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia. Orphanet J Rare Dis 2011;6:3.
46. Hampe CS, Petrosini L, De Bartolo P, et al. Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats. Orphanet J Rare Dis 2013;8:82.
47. Hansen N, Grünewald B, Weishaupt A, et al. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol 2013;239:202-9.
48. Rakocevic G, Raju R, Dalakas MC. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 2004;61:902-4.
49. Raju R, Rakocevic G, Chen Z, et al. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006;129:3270-6.
50. Boronat A, Sabater L, Saiz A, et al. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011;76:795-800.
51. Dinkel K, Rickert M, Möller G, et al. Stiff-man syndrome: identification of 17 beta-hydroxysteroid dehydrogenase type 4 as a novel 80-kDa antineuronal antigen. J Neuroimmunol 2002;130:184-93.
52. McKeon A, Martinez-Hernandez E, Lancaster E, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 2013;70:44-50.
53. Alexopoulos H, Akrivou S, Dalakas MC. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology 2013;81:1962-4.
54. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterization of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014;13:276-86.
55. Folli F, Solimena M, Cofiell R, et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993;328:546-51.
56. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 1993;178:2219-23.
57. Wigge P, McMahon HT. The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci 1998;21:339-44.
58. Jarius S, Stich O, Speck J, et al. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome. J Neuroimmunol 2010;229:219-24.
59. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-60.
60. Hassin-Baer S, Kirson ED, Shulman L, et al. Stiff-person syndrome following West Nile fever. Arch Neurol 2004;61:938-41.
61. Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001;98:3988-91.
62. Schloot NC, Batstra MC, Duinkerken G, et al. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun 1999;12:289-6.
63. Lohmann T, Hawa M, Leslie RD, et al. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 2000;356:31-5.
64. Hänninen A, Soilu-Hänninen M, Hampe CS, et al. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes. Diabetes Metab Res Rev 2010;26:271-9.
65. Skorstad G, Hestvik AL, Vartdal F, et al. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun 2009;32:24-32.
66. Lohmann T, Londei M, Hawa M, et al. Humoral and cellular autoimmune responses in stiff person syndrome. Ann N Y Acad Sci 2003;998:215-22.
67. Costa M, Saiz A, Casamitjana R, et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 2002;129:471-8.
68. Burton AR, Baquet Z, Eisenbarth GS, et al. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. J Immunol 2010;184:4863-70.
69. Pugliese A, Solimena M, Awdeh ZL, et al. Association of HLA-DQB1∗0201 with stiff-man syndrome. J Clin Endocrinol Metab 1993;77:1550-3.
70. Dalakas MC, Fujii M, Li M, et al. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000;55: 1531-5.
71. Floeter MK, Valls-Solé J, Toro C, et al. Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology 1998;51:85-93.
72. Meinck HM, Ricker K, Conrad B. The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J Neurol Neurosurg Psychiatry 1984;47:280-7.
73. Khasani S, Becker K, Meinck HM. Hyperekplexia and stiff-man syndrome: abnormal brainstem reflexes suggest a physiological relationship. J Neurol Neurosurg Psychiatry 2004;75:1265-9.
74. Molloy FM, Dalakas MC, Floeter MK. Increased brainstem excitability in stiff-person syndrome. Neurology 2002;59:449-51.
75. Levy LM, Levy-Reis I, Fujii M, et al. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 2005;62:970-4.
76. Dalakas MC, Li M, Fujii M, et al. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780-4.
77. Koerner C, Wieland B, Richter W, et al. Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity. Neurology 2004;62:1357-62.
78. Sandbrink F, Syed NA, Fujii MD, et al. Motor cortex excitability in stiff-person syndrome. Brain 2000;123:2231-9.
79. Perani D, Garibotto V, Moresco RM, et al. PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord 2007;22:1030-3.
80. Galldiks N, Thiel A, Haense C, et al. 11C-flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome. J Neurol 2008;255:1361-4.
81. Holmøy T, Skorstad G, Alvik KM, et al. Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord. Clin Neurol Neurosurg 2009;111:708-12.
82. Saiz A, Minguez A, Graus F, et al. Stiff-am syndrome with vacuolar degeneration of anterior horn motor neurons. J Neurol 1999;246:858-60.
83. Witherick J, Highley JR, Hadjivassiliou M. Pathological findings in a case of stiff person syndrome with anti-GAD antibodies. Mov Disord 2011;26:2138-9.
84. Ishizawa K, Komori T, Okayama K, et al. Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study. Acta Neuropathol 1999;97:63-70.
85. Warren JD, Scott G, Blumbergs PC, et al. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies. J Clin Neurosci 2002;9:328-9.
86. Poh MQ, Simon NG, Buckland ME, et al. Evidence of T-cell mediated neuronal injury in stiff-person syndrome with anti-amphiphysin antibodies. J Neurol Sci 2014;337:235-7.
87. Baizabal Carvallo JF, Jankovic J. Movement disorders of autoimmune origin. In: Poewe W, Jankovic J, eds. Movement disorders in neurologic and systemic diseases. UK: Cambridge University Press, 2014:179-242.
88. Miller F, Korsvik H. Baclofen in the treatment of stiff-man syndrome. Ann Neurol 1981;9:511-12.
89. Sechi G, Barrocu M, Piluzza MG, et al. Levetiracetam in stiff-person syndrome. J Neurol 2008;255:1721-5.
90. Silbert PL, Matsumoto JY, McManis PG, et al. Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 1995;45:1893-7.
91. Stayer C, Tronnier V, Dressnandt J, et al. Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology 1997;49:1591-7.
92. Ughratdar I, Sivakumar G, Basu S. Spinal cord stimulation to abort painful spasms of atypical stiff limb syndrome. Stereotact Funct Neurosurg 2010;88: 183-6.
93. Davis D, Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993;8:371-3.
94. Dalakas MC, Fujii M, Li M, et al. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001;345:1870-6.
95. Harding AE, Thompson PD, Kocen RS, et al. Plasma exchange and immunosuppression in the stiff man syndrome. Lancet 1989;2:915.
96. De la Casa-Fages B, Anaya F, Gabriel-Ortemberg M, et al. Treatment of stiff-person syndrome with chronic plasmapheresis. Mov Disord 2013;28:396-7.
97. Fekete R, Jankovic J. Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol 2012;4:92-6.
98. Venhoff N, Rizzi M, Salzer U, et al. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study. Ann Rheum Dis 2009;68:1506-8.
99. Baker MR, Das M, Isaacs J, et al. Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry 2005;76:999-1001.
100. Dupond JL, Essalmi L, Gil H, et al. Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis. J Clin Neurosci 2010;17:389-91.
101. Qureshi A, Hennessy M. Stiff person syndrome (SPS) complicated by respiratory failure: successful treatment with rituximab. J Neurol 2012;259:180-1.
102. Kyskan R, Chapman K, Mattman A, et al. Antiglycine receptor antibody and encephalomyelitis with rigidity and myoclonus (PERM) related to small cell lung cancer. BMJ Case Rep 2013;2013:pii: bcr2013010027
103. Rizzi M, Knoth R, Hampe CS, et al. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS ONE 2010;5:e10838.
104. Gerschlager W, Schrag A, Brown P. Quality of life in stiff-person syndrome. Mov Disord 2002;17:1064-7.